Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2006;37:2802-2806
Published online before print September 28, 2006, doi: 10.1161/01.STR.0000245134.12145.ae
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/11/2802    most recent
01.STR.0000245134.12145.aev1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kitayama, J.
Right arrow Articles by Heistad, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kitayama, J.
Right arrow Articles by Heistad, D. D.
Related Collections
Right arrow Oxidant stress
Right arrow Endothelium/vascular type/nitric oxide

(Stroke. 2006;37:2802.)
© 2006 American Heart Association, Inc.


Original Contributions

Modulation of Dilator Responses of Cerebral Arterioles by Extracellular Superoxide Dismutase

Jiro Kitayama, MD; Chu Yi, PhD; Frank M. Faraci, PhD Donald D. Heistad, MD

From the Cardiovascular Center and Departments of Internal Medicine and Pharmacology, University of Iowa Carver College of Medicine and VA Medical Center, Iowa City, Iowa.

Correspondence to Donald D. Heistad, MD, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA 52242-1081. E-mail donald-heistad{at}uiowa.edu

Background and Purpose— Extracellular superoxide dismutase (ECSOD) is highly expressed in the wall of blood vessels and plays an important role in modulation of vascular function in extracranial arteries. Expression of ECSOD appears to affect cerebral vascular responses during disease states. Effects of ECSOD on dilator function in cerebral arterioles, however, have not been fully elucidated. In the present study, we examined effects of ECSOD deficiency on cerebrovascular reactivity under control conditions and during oxidative stress.

Methods— Dilator responses of cerebral arterioles were examined in cranial windows in vivo in anesthetized ECSOD-deficient (–/–) and wild-type (+/+) mice under normal conditions and during oxidative stress induced by angiotensin II.

Results— Total SOD activity in the aorta in ECSOD–/– mice (176±24 [mean±SEM] U/mg) was approximately 30% lower than in ECSOD+/+ mice (270±38, P=0.051). Dilator responses to acetylcholine (10 µmol/L) in cerebral arterioles were similar under control conditions in ECSOD+/+ (34±5% changes in diameter) and –/– mice (32±4%). Angiotensin II (500 nmol/L for 30 minutes) tended to reduce responses to acetylcholine in ECSOD+/+ mice (not significant) and significantly impaired responses in ECSOD–/– mice (42% reduction, P<0.05). Tempol (1 mmol/L), a scavenger of superoxide, restored the impaired dilator responses in ECSOD–/– mice. Responses to nitroprusside in cerebral arterioles were similar in ECSOD+/+ and –/– mice and were not affected by angiotensin II nor by tempol.

Conclusions— ECSOD deficiency has little effect on cerebrovascular reactivity in control conditions but plays an important role in the regulation of vascular tone during oxidative stress produced by angiotensin II.


Key Words: angiotensin II • cerebral circulation • endothelium • nitric oxide • oxidative stress